ALFA Finder| Value | ₹9.56 Cr |
|---|
BSE filing, NSE: ALKEM. Summary written from the filing by ALFA Finder's alert engine.
Alkem Laboratories Ltd: key numbers
- Share price
- ₹5,304.00
- Market cap
- ₹63,417 Cr
- Revenue (annual)
- ₹14,712 Cr
- Net profit (annual)
- ₹2,302 Cr
- P/E (TTM)
- 29.4×Sector 48.6×
- Promoter holding
- 49.70%+0.00% QoQ
- FII holding
- 10.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alkem Laboratories Ltd
All →Alkem Laboratories Board Meeting Date
Alkem Laboratories has scheduled its Board meeting for 12 Nov 2026 to consider Q2 and H1 FY27 unaudited results. No financial figures are disclosed in this advance notice.
Alkem Laboratories Management Change
Alkem Laboratories appointed Dr. Amrut Naik as CEO effective November 11, 2026. The Board designated him as Key Managerial Personnel at its November 3 meeting.
Alkem Laboratories Business Update
Alkem informed the exchange that US FDA completed inspection of its Mandva API facility with no Form 483 observations. The clean result confirms regulatory compliance.
Alkem Laboratories Legal & Regulatory
Alkem Laboratories has initiated a forensic audit by Grant Thornton Bharat LLP following alleged misappropriation of funds by a former employee.
Alkem Laboratories Other Announcement
Alkem Laboratories Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements. This document details the company's equity structure.
Alkem Laboratories Management Change
Alkem Laboratories appointed Laxmikant Tiwari and Nilesh Vartak as Senior Management Personnel effective 12 October 2026. The appointments strengthen pharmaceutical operations and supply chain leadership.
Other merger & restructuring announcements
All →Jubilant Ingrevia Merger & Restructuring
Jubilant Ingrevia updated on a restructuring share subscription and purchase agreement closing in two tranches. First tranche is due by November 2026, second by September 2027.
- Execution
- First tranche by November 2026; second tranche by September 2027
AAA Technologies Merger & Restructuring
AAA Technologies approved four wholly owned subsidiaries in Singapore, Mauritius, Dubai and India. Each entity is in IT security, cybersecurity and technology services.
Tirupati Starch & Chemicals Merger & Restructuring Worth ₹2.98 Cr
Tirupati Starch agreed to sell its Indore immovable property to Usha and Arpit Doshi for Rs 2.98 Crore. Completion is expected by 15 January 2027, subject to conditions.
- Value
- ₹2.98 Cr
- Execution
- Completion expected on or before 15 January 2027
CFF Fluid Control Merger & Restructuring
CFF Fluid Control will form a 51% joint venture with TKMS Atlas Elektronik for anti-submarine warfare in India. No deal value is disclosed.
Trom Industries Merger & Restructuring Worth ₹0.02 Cr
Trom Industries plans to incorporate Trom Energy SPV Private Limited, a solar power subsidiary, holding 98%. The initial cash subscription is Rs 1,96,000 for 19,600 shares.
- Value
- ₹0.02 Cr
Yasons Chemex Care Merger & Restructuring Worth ₹29.61 Cr
Yasons Chemex's subsidiary Rishit Polysurf LLP signed a slump sale agreement to sell its chemical manufacturing business to Vasudha Specialities Emulsifiers. Consideration is Rs.29.61 Crore in cash.
- Value
- ₹29.61 Cr